Navigation Links
Silicone Scandal: Stem Cell Breast Augmentation a Safe Alternative
Date:1/10/2012

VIENNA, Austria, January 10, 2012 /PRNewswire/ --

Stem cell-enriched autologous fat enables sustainable breast augmentation with autologous tissue

It was in all the media: For years a French company has been selling defective silicone implants that often rupture and may cause cancer. More than 100,000 women worldwide must now choose between having their implants removed as a precaution or carrying a "time bomb" in their bodies. Stem cell breast augmentation offers an innovative, safe alternative to silicone implants.

"Autologous fat tissue is better tolerated than silicone and is ideal for scarless, completely natural breast augmentation or breast reconstruction after removal of silicone implants or tumors," says DDr. Karl-Georg Heinrich, Vienna-based esthetic and regenerative stem cell therapy expert. His Clinic DDr. Heinrich® has been granting the wishes of patients worldwide for a fuller décolletage without silicone and scars since 2007.

Like all other approved silicone implants, the defective French implants were also CE certified. The defects of these implants remained hidden. But even the best silicone implants represent only a temporary breast augmentation solution. Hence cosmetic surgeons who use silicone implants recommend implant replacements every ten years for all patients.

With stem cell breast augmentation, however, sustainable breast augmentation is generally achievable with just one intervention under local anesthesia. The autologous fat used for breast augmentation is gently liposuctioned with patented microcannulas, enriched with autologous stem cells, and then injected in the breast with fine injection needles.

Along with breast augmentation and stem cell facelifts, stem cell-enriched autologous fat is used in the Clinic DDr. Heinrich® for body shaping (buttocks, hips, upper thighs, calves) as well as dent correction and skin rejuvenation.

Further information: http://ddrheinrich.com/stem-cell-breast-augmentation

Contact:
Clinic DDr. Heinrich®
Contact: Herfried Wagner
E-mail: info@ddrheinrich.com
Web: http://ddrheinrich.com/
Phone: +43-(0)1-532-18 01



'/>"/>
SOURCE Clinic DDr. Heinrich
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Microban Medical Silver Antimicrobial Technologies for HCR Silicone Achieve 5 Log Reductions in Bacteria Growth and Prevent Biofilm Formation
2. Saint-Gobain Introduces Next Generation Silicone Tubing
3. Polymer Science Releases New Silicone Gel Adhesive Products for MD&M West
4. Bluestar Silicones Presents Adhesive Gels for Wound Care at Medical Grade Polymers Conference
5. BioStorage Technologies Partners with Susan G. Komen for the Cure Tissue Bank at IU Simon Cancer Center to Raise Money and Awareness for Breast Cancer Research
6. Breast Cancer Vaccine Being Developed by Generex Subsidiary Antigen Express to be Featured on Bloomberg Television Today
7. Puma Biotechnology Announces Positive PB272 (Neratinib) Phase II Data at CTRC-AACR San Antonio Breast Cancer Symposium
8. Agendia to Present Five Abstracts at 2011 San Antonio Breast Cancer Symposium
9. Novartis Highlights Advances for Patients With Breast Cancer and Hematological Diseases With Over 160 SABCS and ASH Abstracts
10. US Oncology Research Affiliated Physician to Present Findings From Innovative Clinical Trial at 2011 CTRC-AACR San Antonio Breast Cancer Symposium
11. Hologic to Showcase 3D Mammography (Breast Tomosynthesis) and Other Advanced Womens Imaging Technologies at RSNA 2011, the Largest Radiology Show in the World
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2017)... ... February 23, 2017 , ... ... evaluation of multiple immunoassay-based threat detection technologies by researchers from the Pacific ... biosensor threat detection technology was found to have the best level of ...
(Date:2/23/2017)... ... ... Today, researchers can fast-track sample collection and analysis for ... or SNPs of interest) using one, easy-to-collect saliva sample. With the addition of ... and other relevant biomarkers can be extensively studied through a non-invasive sample type. ...
(Date:2/23/2017)... , Feb. 23, 2017  Capricor Therapeutics, Inc. (NASDAQ: CAPR), ... medical conditions, today announced that Linda Marbán, Ph.D, president and ... investor conferences: Cowen and Company 37th ... am ET Boston, MA ... 9:00 am PT (12:00 pm ET) Dana Point, ...
(Date:2/23/2017)... FRANCISCO , Feb. 23, 2017   ViaCyte, ... Type 1, a not-for-profit advocacy and education group for ... grant from Beyond Type 1 to support ViaCyte,s efforts ... other insulin-requiring diabetes.  For more than ... cell replacement therapies with a focus on the treatment ...
Breaking Biology Technology:
(Date:2/3/2017)... 2017 A new independent identity strategy consultancy ... (IdSP) . Designed to fill a critical niche in ... founding partners Mark Crego and Janice ... in identity expertise that span federal governments, the 9/11 ... Crego-Kephart combined expertise has a common theme born from ...
(Date:2/2/2017)... 1, 2017  Central to its deep commitment ... worldwide, The Japan Prize Foundation today announced the ... pushed the envelope in their respective fields of ... scientists are being recognized with the 2017 Japan ... only contribute to the advancement of science and ...
(Date:1/30/2017)... 2017   Invitae Corporation (NYSE: ... companies, today announced that it will report its fourth ... guidance on Monday, February 13, 2017, and Invitae,s management ... 4:45 p.m. Eastern / 1:45 p.m. Pacific. ... review financial results, guidance, and recent developments and will ...
Breaking Biology News(10 mins):